News archive

GPhC launches consultation on remote hearings

16 November 2021
The General Pharmaceutical Council (GPhC) is consulting on continuing to hold remote hearings in the future

Early opening hours tomorrow

15 November 2021
Ahead of the registration assessment our contact centre will be opening earlier

GPhC launches new strategy to deliver equality, improve diversity and foster inclusion

10 November 2021
Action plan being developed to set out how the new strategy will be implemented

GPhC responds to Government announcement on mandatory COVID-19 vaccinations for NHS frontline staff

10 November 2021
Responding to the announcement that COVID-19 vaccination will be a condition of deployment for NHS staff in England, Duncan Rudkin, Chief Executive of the General Pharmaceutical Council, said

The Council of the GPhC will be meeting on Thursday 11 November

8 November 2021
Please contact our Communications Team if you would like to join the meeting via Zoom, at 13:30. 

The Council of the GPhC will be meeting on Thursday 7 October

6 October 2021
Please contact our Communications Team if you would like to join the meeting via Zoom, at 14:00. 

Revalidation requirements from December 2021

4 October 2021
Pharmacists and pharmacy technicians due to submit their revalidation records from December 2021 to February 2022 will only need to submit a reflective account when they renew their registration.

GPhC launches consultation on changes to requirements for training as a pharmacist independent prescriber

28 September 2021
The General Pharmaceutical Council is consulting on changes which will enable more pharmacists to begin their independent prescriber training

Healthcare regulators publish annual report on whistleblowing disclosures

27 September 2021
The GPhC in conjunction with seven other healthcare professional regulators has published its annual report on whistleblowing disclosures.

GPhC welcomes overprescribing report

23 September 2021
The Government has published a review into overprescribing led by the Chief Pharmaceutical Officer for England, Dr Keith Ridge.